Digital Health IPOs Serve As Litmus Test In Uncertain Markets
While public markets have been turbulent in recent months, digital health companies appear to be bucking the trend, pushing to go public even as others wait on the sidelines.
As Trump Pushes Coal, Miners Fear Health Protection Erosion
A court order restoring a coal miner "black lung" screening program hasn't ended concerns among health and legal advocates that the Trump administration is neglecting miners as it pushes coal production.
Foreign Drugmakers Brace For More Visits Amid FDA Cuts
The U.S. Food and Drug Administration's plan to expand surprise inspections of overseas drug manufacturing plants is a legitimate enforcement threat that should be taken seriously, even as the agency adjusts to a future with a smaller workforce.
Digital Health IPOs Serve As Litmus Test In Uncertain Markets
While public markets have been turbulent in recent months, digital health companies appear to be bucking the trend, pushing to go public even as others wait on the sidelines.
As Trump Pushes Coal, Miners Fear Health Protection Erosion
A court order restoring a coal miner "black lung" screening program hasn't ended concerns among health and legal advocates that the Trump administration is neglecting miners as it pushes coal production.
Foreign Drugmakers Brace For More Visits Amid FDA Cuts
The U.S. Food and Drug Administration's plan to expand surprise inspections of overseas drug manufacturing plants is a legitimate enforcement threat that should be taken seriously, even as the agency adjusts to a future with a smaller workforce.
Expert Analysis
.png)
Recent artificial intelligence developments in Canada's health industry are creating ripple effects for global inv... (more story)
The emergence of psychedelic therapies as potential treatments for mental health conditions and other ailments con... (more story)
More time is needed to study three Texas bills aimed at considering the effects of healthcare consolidation to inc... (more story)
Deals & Corporate Governance More
The Federal Trade Commission has requested additional information about Swiss eye care company Alcon Inc.'s planned purchase of Florida-based medical technology developer Lensar Inc. in a deal worth up to $430 million.
A former board member at Chinook Therapeutics orchestrated an insider-trading scheme after learning about Novartis' plans to purchase the biotech company for $3.5 billion in 2023, according to an indictment announced Friday.
Mylan Pharmaceuticals' $73.5 million settlement with a class of direct EpiPen buyers has received final approval from a Kansas federal judge, closing out claims from institutional drug resellers that Mylan wor... (more story)
Bankrupt drugmaker Nostrum Laboratories received approval from a New Jersey court for a $1.75 million sale of an Ohio facility after reaching an agreement with the buyer and lenders over the costs of removing ... (more story)
The Eighth Circuit should once again say no to a request to pause the Federal Trade Commission's in-house case accusing three pharmacy benefit managers of hiking up the price of insulin to line their own pocke... (more story)
An Illinois state appellate panel said Wednesday that a trial court properly dismissed a shareholder class action against biopharmaceutical company AbbVie Inc. that accused the drugmaker of issuing unregistere... (more story)
Digital Health & Technology More
A California federal judge ruled Thursday that Flo Health Inc. and Meta cannot escape all the claims in a class action brought by users of a menstrual cycle app who allege their privacy was violated, denying p... (more story)
A Washington state judge has given final approval to an $11.5 million class action settlement to end litigation against Seattle-based Fred Hutchinson Cancer Center over a 2023 data breach that exposed patient ... (more story)
Two California clinics that provide stem cell treatments are urging the U.S. Supreme Court to review a Ninth Circuit panel's finding that their treatments are "drugs" subject to Food, Drug and Cosmetic Act regulations.
A California federal judge has granted class status to users of the menstrual cycle tracking app developed by Flo Health Inc. in a suit accusing the company of unlawfully sharing their personal health informat... (more story)
The U.S. Department of Health and Human Services and several constituent agencies are accused of violating the Administrative Procedure Act by illegally purging websites containing critical public health infor... (more story)
Investors in biotech company Intellia Therapeutics Inc. stock opened a derivative suit in Delaware's Court of Chancery on Tuesday seeking recovery of allegedly excessive compensation paid to non-employee direc... (more story)
Policy & Compliance More
A new suit by two Colorado doctors and an out-of-state patient challenges a state restriction barring nonresidents from accessing a form of healthcare legalized in Colorado allowing patients to receive a docto... (more story)
A Virginia federal judge has sentenced a disbarred attorney and former McKinsey & Co. partner to six months in prison for obstructing an investigation into the consulting giant's work with opioid manufacturer ... (more story)
A Massachusetts federal judge on Friday ordered the U.S. Department of Health and Human Services to restore articles penned by two Harvard Medical School researchers that contained terms like "transgender" and... (more story)
A Pennsylvania federal judge has certified a class of health plans in multidistrict litigation over GlaxoSmithKline's alleged deceptive marketing of the drug Avandia in which the plans claim they wouldn't have... (more story)
An orthopedic clinic is urging North Carolina's highest court to free it from a family's negligent-retention claim over an allegedly faulty surgery by a doctor who later lost his license, asserting that the lo... (more story)
Vanda Pharmaceuticals Inc. is asking the U.S. Supreme Court to reverse the Food and Drug Administration's decision denying fast-track approval for its gastroparesis drug tradipitant, saying it meets the statut... (more story)